• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Eisai finds an exit from Aduhelm, with small royalties if it ever nabs coverage – Endpoints News


<